Cambrex Videos

  1. Ask Us Anything: Antje Gupta On Biocatalysts In Process Development 7/23/2026

    Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

  2. Ask Us Anything: Anmaris Torres On The First Steps In Process Transfer 7/23/2026

    Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

  3. Ask Us Anything: Daniele Vigo On Cost-Effective Process Development 7/23/2026

    Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

  4. Ask Us Anything: David Ford On AI And Automation Trends 7/23/2026

    David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.

  5. Working With Clients To Develop Manufacturing Processes 7/23/2026

    Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.

  6. Ask Us Anything: Ingrid Ekman On Using Technology To Optimize R&D 7/23/2026

    Ingrid Ekman, Director of R&D at Cambrex Karlskoga, on why smoother tech transfer starts much earlier than most teams think — with systematic data and design of experiments that map a process's boundaries before it ever reaches commercial scale.

  7. Ask Us Anything: Matthew Bio On Driving Innovation In API Development 7/23/2026

    Join Matthew Bio, Ph.D., Chief Scientific Officer at Cambrex, as he shares how scientific collaboration and innovation are helping shape the future of pharmaceutical development.

  8. Ask Us Anything: Matt Bio On Peptide Commercialization Trends 7/23/2026

    Matt Bio, CSO of Cambrex and President of Snapdragon Chemistry, on the capacity bottleneck behind peptide shortages — and why moving from solid-phase to liquid-phase synthesis unlocks reactors already sitting idle around the world.

  9. Ask Us Anything: Matthew Schiesher On Validation During Tech Transfer 7/23/2026

    Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

  10. Ask Us Anything: Miles Blackburn On Advances In Flow And Radical Chemistry 7/23/2026

    Miles Blackburn, Associate Director of Chemistry at Snapdragon Chemistry, on why the biggest payoff of flow and radical chemistry is speed — processes that scale fast enough to get intermediates and APIs delivered on a clinical timeline.